WO2002083077A3 - Nouveau gene humain associe aux maladies respiratoires, a l'obesite et aux affections abdominales inflammatoires - Google Patents

Nouveau gene humain associe aux maladies respiratoires, a l'obesite et aux affections abdominales inflammatoires Download PDF

Info

Publication number
WO2002083077A3
WO2002083077A3 PCT/US2002/012063 US0212063W WO02083077A3 WO 2002083077 A3 WO2002083077 A3 WO 2002083077A3 US 0212063 W US0212063 W US 0212063W WO 02083077 A3 WO02083077 A3 WO 02083077A3
Authority
WO
WIPO (PCT)
Prior art keywords
obesity
relates
inflammatory bowel
bowel disease
human gene
Prior art date
Application number
PCT/US2002/012063
Other languages
English (en)
Other versions
WO2002083077A2 (fr
Inventor
Tim Keith
Randall D Little
Eerdewegh Paul Van
Josee Dupuis
Mastro Richard G Del
Jason Simon
Kristina Allen
Sunil Pandit
Original Assignee
Schering Corp
Genome Therapeutics Corp
Tim Keith
Randall D Little
Eerdewegh Paul Van
Josee Dupuis
Mastro Richard G Del
Jason Simon
Kristina Allen
Sunil Pandit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/834,597 external-priority patent/US20030138925A1/en
Application filed by Schering Corp, Genome Therapeutics Corp, Tim Keith, Randall D Little, Eerdewegh Paul Van, Josee Dupuis, Mastro Richard G Del, Jason Simon, Kristina Allen, Sunil Pandit filed Critical Schering Corp
Priority to AU2002307369A priority Critical patent/AU2002307369A1/en
Publication of WO2002083077A2 publication Critical patent/WO2002083077A2/fr
Publication of WO2002083077A3 publication Critical patent/WO2002083077A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des gènes identifiés sur le chromosome humain 20p13-p12, qui sont associés à diverses pathologies, dont l'asthme. L'invention concerne également les séquences nucléotidiques de ces gènes, les acides nucléiques isolés comprenant ces séquences nucléotidiques et les polypeptides ou peptides isolés codés par ces séquences. L'invention concerne en outre des vecteurs et des cellules hôtes comprenant les séquences nucléotidiques décrites, ou des fragments de celles-ci, ainsi que des anticorps qui se fixent sur les polypeptides ou peptides codés. L'invention concerne encore des ligands qui modulent l'activité des gènes ou des produits géniques décrits, ainsi que des méthodes et des compositions dans lesquelles les acides nucléiques, polypeptides ou peptides, anticorps et/ou ligands sont utilisés pour le diagnostic et le traitement de l'asthme et d'autres pathologies.
PCT/US2002/012063 2001-04-13 2002-04-15 Nouveau gene humain associe aux maladies respiratoires, a l'obesite et aux affections abdominales inflammatoires WO2002083077A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002307369A AU2002307369A1 (en) 2001-04-13 2002-04-15 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/834,597 2001-04-13
US09/834,597 US20030138925A1 (en) 2000-04-13 2001-04-13 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
USPCT/US01/12245 2001-04-13
PCT/US2001/012245 WO2001078894A2 (fr) 2000-04-13 2001-04-13 Nouveau gene humain implique dans les maladies respiratoires, l'obesite et les maladies intestinales inflammatoires

Publications (2)

Publication Number Publication Date
WO2002083077A2 WO2002083077A2 (fr) 2002-10-24
WO2002083077A3 true WO2002083077A3 (fr) 2003-09-12

Family

ID=26680461

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/012063 WO2002083077A2 (fr) 2001-04-13 2002-04-15 Nouveau gene humain associe aux maladies respiratoires, a l'obesite et aux affections abdominales inflammatoires

Country Status (2)

Country Link
AU (1) AU2002307369A1 (fr)
WO (1) WO2002083077A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6683165B1 (en) 1999-04-13 2004-01-27 Genome Therapeutics Corporation Human gene relating to respiratory diseases and obesity
ES2598829T3 (es) * 2011-03-28 2017-01-30 S.I.S. Shulov Innovative Science Ltd. Procedimiento de tratamiento de trastornos cutáneos

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001009293A2 (fr) * 1999-08-03 2001-02-08 Zymogenetics, Inc. Peptides proteases a adhesion mammalienne (mapp)

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001009293A2 (fr) * 1999-08-03 2001-02-08 Zymogenetics, Inc. Peptides proteases a adhesion mammalienne (mapp)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 7 July 2000 (2000-07-07), WATERSTON R.H., XP002222721, accession no. NCBI Database accession no. (AC017113) *
DATABASE GENBANK [online] NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION, NATIONAL LIBRARY OF MEDICINE, NIH (BETHESDA, MD, USA); 24 October 2000 (2000-10-24), HATTORI M. ET AL., XP002965569, accession no. NCBI Database accession no. (AP002898) *

Also Published As

Publication number Publication date
WO2002083077A2 (fr) 2002-10-24
AU2002307369A1 (en) 2002-10-28

Similar Documents

Publication Publication Date Title
WO2001070174A8 (fr) Genes modules par vegf et leurs procedes d'utilisation
EP1601766A4 (fr) Methodes de construction de banque de fragments geniques biodivers et modulateurs biologiques isoles a partir de ceux-ci
WO2001055308A3 (fr) Acides nucleiques, proteines et anticorps
EP1005540A4 (fr) Proteines ikk-beta, acides nucleiques et procedes
WO2006128668A3 (fr) Polypeptides du facteur x de coagulation possedant des proprietes d'activation modifiees
WO2005113587A3 (fr) Produits geniques d'expression differentielle dans les tumeurs et leur utilisation
JP2002535956A5 (fr)
WO2000066739A3 (fr) Antigenes de chlamydia, fragments d'adn correspondants et utilisation de ceux-ci
WO2002014500A3 (fr) Genes humains et produits d'expression genique
WO1999053040A3 (fr) Sequences d'acide nucleique humain provenant de tissu de tumeur ovarienne
WO2001066753A3 (fr) Nouveaux genes humains et leurs produits d'expression
WO2001098491A3 (fr) Polymorphismes genetiques d'osteolevine
WO2001014420A3 (fr) Nouveaux plexines et leurs utilisations
WO2003050236A3 (fr) Genes humains et produits d'expression geniques isoles d'une prostate humaine
WO2003031594A3 (fr) Sequences de nucleotides et d'acides amines associees a des maladies respiratoires et a l'obesite
WO2001078894A3 (fr) Nouveau gene humain implique dans les maladies respiratoires, l'obesite et les maladies intestinales inflammatoires
WO2005019259A3 (fr) Variants de l'antagoniste du recepteur d'interleukine-1: compositions et utilisations correspondantes
WO2002004513A3 (fr) Proteines 1 du type region critique 1 du syndrome de down
WO2002083077A3 (fr) Nouveau gene humain associe aux maladies respiratoires, a l'obesite et aux affections abdominales inflammatoires
WO2002095067A3 (fr) Nouveaux polynucleotides et polypeptides du gene ifnα-14
EP2172214A3 (fr) Antigènes de Chlamydia et fragments d'ADN correspondants, et leurs utilisations
WO2003000896A3 (fr) Nouveaux polynucleotides et polypeptides du gene ifn$g(a)-5
WO2002101048A3 (fr) Nouveaux polynucleotides et polypeptides du gene ifn$g(a)-7
WO2002055700A3 (fr) Genes humains et produits d'expression genetique isoles de la prostate humaine
MXPA01004353A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP